TradeTrade
Jump to any asset 849 assets, updated daily

Celestica vs Super Micro Computer

CLS

Celestica Inc. NYSE

$316.73 ▲ 0.21%
VS

SMCI

Super Micro Computer Inc. NASDAQ

$36.74 ▼ 8.38%
Last updated: (1m ago) • CLS at $316.73, SMCI at $36.74
CleaRank Financial AIData from TwelveData
Reviewed by CleaRank editorial team. Data refreshed daily. Not financial advice.

Comparative Analysis

SMCI wins this head-to-head comparison due to its superior revenue growth and recent strong earnings performance, indicating significant market momentum. While CLS shows a solid foundation with higher profitability margins and a more favorable analyst target, SMCI's explosive growth trajectory and recent positive earnings surprises present a more compelling investment case for investors seeking high-growth opportunities. SMCI's technicals, though showing some recent weakness, are supported by longer-term upward trends and a lower valuation multiple compared to CLS. The market appears to be pricing in substantial future growth for SMCI, which has been consistently delivered in recent quarters. CLS, while a stable performer, lacks the same aggressive growth narrative that is currently driving SMCI's valuation. Investors prioritizing growth and potential upside should favor SMCI, while those seeking stability and consistent profitability might lean towards CLS.

Key Differentiator

SMCI's explosive revenue growth and recent outsized earnings beat are the primary differentiators, signaling strong market demand and execution in a high-growth sector. While CLS offers superior profitability and a more favorable analyst consensus, SMCI's momentum and lower valuation multiple present a more compelling growth narrative. The market is currently rewarding SMCI's rapid expansion more than CLS's stable profitability, making its growth trajectory the decisive factor.

Joint Outlook

SMCI is positioned for continued strong performance if it can maintain its impressive revenue growth and capitalize on demand in the AI infrastructure sector. Upside scenarios involve further market share gains and successful product innovation, potentially pushing its price towards analyst targets. Downside risks include increased competition or a broader market downturn impacting growth stocks. CLS is expected to provide steady, profitable growth, with its outlook tied to its sector's overall health and its ability to maintain market leadership. Upside scenarios involve continued margin expansion and market share gains, while downside risks include competitive pressures and macroeconomic slowdowns affecting its premium valuation. SMCI's outlook is characterized by higher potential reward and higher volatility, while CLS offers a more stable, albeit potentially less explosive, growth path.

Price Analysis Comparison

Valuation Metrics i

Valuation Metrics: CLS vs SMCI
Metric CLS SMCI
P/E Ratio 32.82 11.27
Market Cap 39.86B 24.14B
Price/Sales 2.56 0.62
Price/Book 14.66 2.35
EV/EBITDA 23.56 10.65
Dividend Yield N/A N/A
SMCI trades at a significantly lower P/E ratio of 11.27 compared to CLS's 32.82, suggesting SMCI is more attractively valued on an earnings basis. Despite SMCI's lower net profit margin (5.71%) versus CLS's 7.16%, its P/E multiple implies greater future earnings growth expectations. CLS's higher return on equity (52.69%) and return on assets (10.8%) indicate superior capital efficiency, but this is priced at a premium. SMCI's market capitalization is also slightly lower than CLS's, offering potential for greater percentage gains if growth continues. The median analyst target for SMCI ($42.5) suggests considerable upside from its current price, while CLS's median target ($480) also indicates upside but from a higher starting point and valuation. SMCI's valuation appears more favorable for aggressive growth investors.

Profitability & Efficiency i

Profitability & Efficiency: CLS vs SMCI
Metric CLS SMCI
Rev. Growth (Qtly) 62.40% 93.20%
Profit Margin 7.16% 5.71%
Return on Equity 52.69% 21.47%
Return on Assets 10.80% 7.88%
Debt/Equity 39.57 63.95
CLS exhibits superior profitability with a net profit margin of 7.16% and a return on equity of 52.69%, significantly outperforming SMCI's 5.71% net profit margin and 21.47% return on equity. CLS also boasts a higher return on assets at 10.8% compared to SMCI's 7.88%. These metrics highlight CLS's greater efficiency in generating profits from its assets and shareholder equity. Despite SMCI's impressive revenue growth, its profitability metrics lag behind CLS, suggesting that CLS is more effective at converting revenue into bottom-line profit and shareholder value. Investors prioritizing consistent profitability and capital efficiency would find CLS more attractive.

Earnings Reality Check i

CLS

Last 5 Qs: CLS beat estimates 5x out of 5. Fell 3x after beats. (Sell the news?)

SMCI

Last 4 Qs: SMCI beat estimates 3x out of 4. Rose 3x after beats.

Technical Indicators

Technical indicators: CLS vs SMCI
Indicator CLS SMCI
RSI (14) 52.93 53.91
50-Day MA $324.90 $32.72
200-Day MA $328.77 $31.51
SMCI's technical indicators present a mixed but potentially bullish picture, with a positive MACD (1.42) suggesting upward momentum, though its RSI (53.91) and CCI (-67.15) indicate it is neither overbought nor oversold, with some recent weakness. Its stochastic oscillator (18.81) is in oversold territory, potentially signaling a near-term bounce. SMCI is trading above its 50-day ($32.72) and 200-day ($31.51) moving averages, confirming a longer-term uptrend. CLS, conversely, shows a neutral RSI (52.93) and CCI (28.34), with a slightly negative MACD (-0.32) indicating a loss of recent upward momentum. CLS is trading below its 50-day ($324.90) and 200-day ($328.77) moving averages, suggesting potential resistance and a less favorable short-term technical setup. SMCI's longer-term technical support levels appear stronger.

AI Analyst Sentiment

Technical rating: based on current price action versus moving averages and momentum. This measures short-term chart trend, not analyst opinion or company fundamentals.

CLS

Buy
Technical Score: 79/100

SMCI

Hold
Technical Score: 54/100
Analyst sentiment for CLS is overwhelmingly positive, with 20 analysts rating it as Strong Buy (5) or Buy (15), and a median target price of $480, suggesting significant upside potential. SMCI's analyst ratings are more divided, with 5 Strong Buys/Buys against 13 Holds/Sells, and a median target of $42.5, which still offers upside from its current price but indicates less consensus. The strong buy-side sentiment and higher median target for CLS suggest greater institutional conviction in its long-term prospects. However, SMCI's recent strong earnings surprise may be shifting sentiment positively, despite the current rating distribution. CLS's analyst consensus is a clear positive differentiator.
Note: While CLS shows stronger short-term technical momentum (Buy 79/100), the AI comparative analysis favors SMCI (Hold 54/100) based on its overall trend structure, fundamentals, and risk-adjusted outlook.

Risk Stratification i

Risk metrics: CLS vs SMCI
Metric CLS SMCI
Beta (Volatility) i 1.46 2.00
Sharpe Ratio 1.35 0.09
SMCI faces the risk of its high revenue growth not translating into sustained profitability or if its current valuation multiples contract due to market sentiment shifts or increased competition in the AI infrastructure space. A slowdown in demand for its specialized hardware or a failure to maintain its technological edge could significantly impact its stock price. CLS's risks include potential market saturation in its sector, increased regulatory scrutiny, or a slowdown in its impressive revenue growth, which could lead to a re-rating of its premium valuation. Competition and macroeconomic headwinds impacting consumer or enterprise spending could also pressure CLS's performance. Both stocks carry execution risk, but SMCI's rapid growth carries a higher inherent volatility.

Comparative ProTips

  • Monitor SMCI's ability to sustain its high revenue growth rate in upcoming quarters; any deceleration could pressure its valuation.
  • Consider CLS for its stable profitability and strong analyst backing, but be aware of its premium valuation and slower growth compared to SMCI.
  • The divergence in analyst sentiment is notable; SMCI's mixed ratings suggest higher risk but potentially greater reward if it continues its growth trajectory.

Monte Carlo Projection (10yr)

Actionable Trade Plans

Compare entry, exit, and risk management levels for both assets

Select Your Trade Bias
Risk Tolerance
Conservative 3% Aggressive
Portfolio Value
$
Position Size: $200 - $300 per asset
CLS
Current: $316.73
ENTRY ZONES
$300.89
$316.73
RISK MANAGEMENT
STOP LOSS
$291.87
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$315.94
+10%
$330.98
+15%
$346.03
SMCI
Current: $36.74
ENTRY ZONES
$34.90
$36.74
RISK MANAGEMENT
STOP LOSS
$33.86
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$36.65
+10%
$38.39
+15%
$40.14
Disclaimer
This comparison involves assets with varying risk profiles. The content is for educational purposes only. Comparison includes a higher-volatility asset (CLS). Correlations between assets with different volatility profiles can break down rapidly during market stress. Liquidity risks may prevent execution at displayed prices.

Note: The AI favored SMCI based on price momentum. This is valid for the specified timeframe only. While CLS currently shows the stronger short-term technical score (79 vs 54), the AI favors SMCI on the factors above rather than today's technical setup.

Frequently Asked Questions

Which is a better buy, CLS or SMCI?+
SMCI is currently a better buy for investors seeking high growth, driven by its exceptional revenue expansion and recent earnings beats. CLS offers more stability and profitability but lacks SMCI's current growth momentum.
What are the key risks for SMCI compared to CLS?+
SMCI risks include maintaining its rapid growth trajectory and facing potential valuation compression if growth slows. CLS risks include market saturation and potential re-rating if its premium valuation is not supported by continued strong performance.
How do CLS and SMCI compare on valuation metrics?+
SMCI trades at a significantly lower P/E ratio (11.27) than CLS (32.82), making it appear more attractively valued despite CLS's higher profitability margins.
Which stock has stronger recent earnings performance?+
SMCI demonstrated a much larger positive earnings surprise (77.08%) in its latest quarter, leading to a significant price increase, while CLS also had positive surprises but with less dramatic price reactions.
How do analyst ratings differ for CLS and SMCI?+
CLS has a stronger analyst consensus with a 'Strong Buy' to 'Buy' ratio and a higher median target price, indicating greater institutional confidence compared to SMCI's more mixed ratings.
What are the technical outlooks for CLS and SMCI?+
SMCI shows longer-term technical support with its price above key moving averages and an oversold stochastic, suggesting potential for a bounce. CLS is trading below its key moving averages, indicating potential short-term headwinds.
How do their profitability margins compare?+
CLS exhibits superior profitability with a net profit margin of 7.16% and return on equity of 52.69%, compared to SMCI's 5.71% net profit margin and 21.47% return on equity.

People Also Watch

Disclaimer: CleaRank.com is a financial data and analytics provider, not a registered investment advisor, broker-dealer, or financial regulatory body. This AI-generated comparison of CLS vs SMCI is for educational and informational purposes only and does not constitute financial advice, investment recommendations, or an offer to buy or sell any securities or digital assets. The comparison metrics, trade plans, and AI signals are hypothetical, hindsight-based, and simulated. Different asset classes carry different risk profiles - stocks, ETFs, cryptocurrencies, commodities, and forex each have unique regulatory frameworks and risk factors. Market data is provided "as-is" and may be delayed by 15 minutes or more. Past performance does not guarantee future results. You should never invest money you cannot afford to lose. Consult a qualified financial advisor before making any investment decisions. Analysis generated on September 15, 2026.

Disclaimer:

Engaging in financial markets carries significant risk of total capital loss. Markets are volatile, unpredictable, and past success does not guarantee future results. Never invest funds you cannot afford to lose. CleaRank does not offer financial, investment, or advisory services. We provide no recommendations, endorsements, or guarantees regarding market outcomes. You alone are responsible for your decisions.

Advertiser Disclosure:

At CleaRank, clarity and transparency are more than ideals, they are the core of our operations. CleaRank is a paid SaaS platform: the Pro and Ultra workbench plans are paid subscriptions, while everything else on this site, including our trading calculators, tools and market news, is free to use. In the spirit of full disclosure: some of our free editorial content contains partner links, and we may earn affiliate commissions from them. This never affects what you pay. Please keep in mind that your confidence in our platform is what matters to us most and we are devoted to earning your trust every day through consistent transparency. CleaRank's Editorial team works independently from partner relationships and financial incentives. All material and information made available by CleaRank stem from our unique technology and methodology which are created to prioritize your needs as a trader and deliver actionable insights to help you make clearer decisions.